000 01098 a2200301 4500
005 20250514062139.0
264 0 _c20030711
008 200307s 0 0 eng d
022 _a0890-9091
040 _aNLM
_beng
_cNLM
100 1 _aNabhan, Chadi
245 0 0 _aCurrent status of monoclonal antibody therapy for chronic lymphocytic leukemia.
_h[electronic resource]
260 _bOncology (Williston Park, N.Y.)
_cFeb 2003
300 _a253-62; discussion 264, 267, passim p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAntibodies, Monoclonal
_xadministration & dosage
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aClinical Trials as Topic
650 0 4 _aDisease-Free Survival
650 0 4 _aHumans
650 0 4 _aLeukemia, Lymphocytic, Chronic, B-Cell
_xdiagnosis
650 0 4 _aNeoplasm Staging
650 0 4 _aPrognosis
700 1 _aDyer, Martin J
700 1 _aRosen, Steven T
773 0 _tOncology (Williston Park, N.Y.)
_gvol. 17
_gno. 2
_gp. 253-62; discussion 264, 267, passim
999 _c12427691
_d12427691